Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, April 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 307 articles:
HTML format


 

Single Articles

  1. LI T, Zhang W, Niu M, Wu Y, et al
    STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
    Front Immunol. 2024;15:1342647.
    PubMed    
    Abstract available

  2. INTERNATIONAL BR
    Retracted: LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
    Biomed Res Int. 2024;2024:9769120.
    PubMed    
    Abstract available

  3. CAROBELI LR, Santos ABC, Martins LBM, Damke E, et al
    Recent advances in photodynamic therapy combined with chemotherapy for cervical cancer: a systematic review.
    Expert Rev Anticancer Ther. 2024 Mar 28. doi: 10.1080/14737140.2024.2337259.
    PubMed    
    Abstract available

  4. COLLARINO A, Feudo V, Pasciuto T, Florit A, et al
    Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
    J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044.
    PubMed    
    Abstract available

  5. KAMBLE A, Naik S, Talathi M, Jadhav D, et al
    Exploring the diversity of vaginal microbiota between healthy women and cervical cancer patients in India.
    J Med Microbiol. 2024;73.
    PubMed    
    Abstract available

  6. KROON KR, Bogaards JA, Heideman DA, Meijer CJ, et al
    Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies in cervical cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed    
    Abstract available

  7. WANG X, Chang Y, Pei X, Xu XG, et al
    A prior-information-based automatic segmentation method for the clinical target volume in adaptive radiotherapy of cervical cancer.
    J Appl Clin Med Phys. 2024 Mar 28:e14350. doi: 10.1002/acm2.14350.
    PubMed    
    Abstract available

  8. CHANGADE JV, Thanvi H, Raut C, Chavan M, et al
    In vitro Evaluation of Anti-Cancer Potential of Different Solvent Extracts Derived from Clerodendrum Infortunatum Linn against Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:1065-1075.
    PubMed    
    Abstract available

  9. SHAMSI U, Zahid F, Abdul Jabbar AB, Musharraf MD, et al
    Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical Cancer in Pakistan: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2024;25:813-820.
    PubMed    
    Abstract available

  10. PAL D, Sahoo BK, Taywade M, Maji S, et al
    Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus Vaccination at the Community Level in India: A Systematic Review and Meta-analysis.
    Asian Pac J Cancer Prev. 2024;25:793-800.
    PubMed    
    Abstract available

  11. PATIL-TAKBHATE BR
    Cervical Cancer Screening Revolution: Advancements with Confocal Endomicroscopy.
    Asian Pac J Cancer Prev. 2024;25:723-724.
    PubMed    


  12. WARLI SM, Tala MRZ, Wijaya WS
    Predictive Factors of Successful Double J Stent Insertion Among Advanced Cervical Cancer Patients.
    World J Oncol. 2024;15:239-245.
    PubMed    
    Abstract available

  13. LOONEN AJM, Verhagen F, Luijten-de Vrije I, Lentjes-Beer M, et al
    Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program.
    Front Cell Infect Microbiol. 2024;14:1330844.
    PubMed    
    Abstract available

  14. HERNANDEZ-SILVA CD, Ramirez de Arellano A, Pereira-Suarez AL, Ramirez-Lopez IG, et al
    HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.
    Viruses. 2024;16:327.
    PubMed    
    Abstract available

  15. GARCIA-ROCHA R, Monroy-Garcia A, Vazquez-Cruz AL, Marin-Aquino LA, et al
    Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-beta Production through Its Interaction with A(2A)R/A(2B)R.
    Pharmaceuticals (Basel). 2024;17:397.
    PubMed    
    Abstract available

  16. LEE WT, Wu PY, Cheng YM, Huang YF, et al
    Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.
    Int J Mol Sci. 2024;25:3191.
    PubMed    
    Abstract available

  17. JUNG L, Klamminger GG, Bier B, Eltze E, et al
    From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening-A Historical Outline of Cervical Carcinoma and Its Relation to HPV Infection.
    Life (Basel). 2024;14:307.
    PubMed    
    Abstract available

  18. LOCKWOOD L, Ju X, Sethi S, Hedges J, et al
    Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types among Indigenous Australians.
    Int J Environ Res Public Health. 2024;21:307.
    PubMed    
    Abstract available

  19. COSTA AS, Baracat EC, Junior JMS, Sorpreso ICE, et al
    Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
    Int J Environ Res Public Health. 2024;21:303.
    PubMed    
    Abstract available

  20. SCHETTINO MT, Preti EP, Vietri V, Agrillo N, et al
    The Role of beta1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions.
    Medicina (Kaunas). 2024;60:364.
    PubMed    
    Abstract available

  21. VITKAUSKAITE A, Urboniene D, Celiesiute J, Jariene K, et al
    Expression of Inflammation Depending on the Stage of Cervical Cancer.
    Medicina (Kaunas). 2024;60:349.
    PubMed    
    Abstract available

  22. ALMOROX L, Antequera L, Rojas I, Herrera LJ, et al
    Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Genes (Basel). 2024;15:312.
    PubMed    
    Abstract available

  23. MOREAU M, Keno LS, China D, Mao S, et al
    Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment.
    Cancers (Basel). 2024;16:1212.
    PubMed    
    Abstract available

  24. PHILLIPS V, Franco Montoya D, Adams EK
    Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review.
    Cancers (Basel). 2024;16:1134.
    PubMed    
    Abstract available

  25. BIANCHI T, Grassi T, Di Martino G, Negri S, et al
    Low-Volume Metastases in Cervical Cancer: Does Size Matter?
    Cancers (Basel). 2024;16:1107.
    PubMed    
    Abstract available

  26. ELISSA N, Charbel H, Marly A, Ingrid N, et al
    Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old.
    Reprod Health. 2024;21:40.
    PubMed    
    Abstract available

  27. HINKES S, Ciraldo K, Kobetz E, Bartholomew TS, et al
    Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.
    Harm Reduct J. 2024;21:70.
    PubMed    
    Abstract available

  28. AKAKPO PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A, et al
    The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
    BMC Infect Dis. 2024;24:356.
    PubMed    
    Abstract available

  29. LI C, Li Q, Li L, Sun S, et al
    The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:97.
    PubMed    
    Abstract available

  30. AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al
    Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
    Anticancer Res. 2024;44:1583-1589.
    PubMed    
    Abstract available

  31. TANIM MTH, Nath SD, Khan SF, Khan A, et al
    Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs.
    Cancer Treat Res Commun. 2024;39:100808.
    PubMed    
    Abstract available

  32. GAO Y, Gonzalez Y, Nwachukwu C, Albuquerque K, et al
    Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
    Phys Med Biol. 2024 Mar 27. doi: 10.1088/1361-6560/ad3880.
    PubMed    
    Abstract available

  33. YAN K, Hu C, Cheng Y, Zheng L, et al
    Circ_0020460 drives tumorigenesis in cervical cancer through miR-485-3p sponging.
    Discov Oncol. 2024;15:88.
    PubMed    
    Abstract available

  34. TANG XH, Zhao TN, Guo L, Liu XY, et al
    Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation.
    Cell Biochem Biophys. 2024 Mar 27. doi: 10.1007/s12013-024-01251.
    PubMed    
    Abstract available

  35. ZHENG X, Shen F, Chen W, Ren W, et al
    Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
    Abdom Radiol (NY). 2024 Mar 27. doi: 10.1007/s00261-024-04270.
    PubMed    
    Abstract available

  36. KAYA TERZI N, Yulek O
    Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies.
    Diagnostics (Basel). 2024;14:611.
    PubMed    
    Abstract available

  37. YING L, Kong L, Qiu X, Cheng A, et al
    A novel mitochondria-related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single-cell validation.
    J Cell Mol Med. 2024;28:e18265.
    PubMed    
    Abstract available

  38. KIM M, Kim E
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol. 2024;96:e29558.
    PubMed    
    Abstract available

  39. HARPER DM, Yu TM, Fendrick AM
    Lives Saved Through Increasing Adherence to Follow-Up After Abnormal Cervical Cancer Screening Results.
    O G Open. 2024;1:e001.
    PubMed    
    Abstract available

  40. POPOVIC A, Bojic MD, Bojic M, Vukmirovic F, et al
    Cutaneous metastases of cervical cancer: a rare entity and possible mechanisms of dissemination.
    Postepy Dermatol Alergol. 2024;41:136-138.
    PubMed    


  41. ZHAO W, Li Q, Wen S, Li Y, et al
    Novel biomarkers of inflammation-associated immunity in cervical cancer.
    Front Oncol. 2024;14:1351736.
    PubMed    
    Abstract available

  42. GONCALVES-NOBRE JG, Matos A, Carreira M, Santos AC, et al
    The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Front Cell Infect Microbiol. 2024;13:1251913.
    PubMed    
    Abstract available

  43. KANG HB, Kim SH, Lee JH, Lee HC, et al
    MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
    Int J Clin Oncol. 2024 Mar 26. doi: 10.1007/s10147-024-02490.
    PubMed    
    Abstract available

  44. ALBANO C, Biolatti M, Mazibrada J, Pasquero S, et al
    PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
    Front Cell Infect Microbiol. 2024;14:1359367.
    PubMed    
    Abstract available

  45. KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
    Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Front Immunol. 2024;15:1391710.
    PubMed    
    Abstract available

  46. WONGPRATATE M, Bumrungthai S
    Cervical cancer in Thailand: 2023 update.
    Obstet Gynecol Sci. 2024 Mar 25. doi: 10.5468/ogs.23277.
    PubMed    
    Abstract available

  47. CHENG S, Gao H, Li Y, Shi X, et al
    Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis in Patients With Cervical Cancer.
    Clin Appl Thromb Hemost. 2024;30:10760296241240747.
    PubMed    
    Abstract available

  48. VOIDAZAN TS, Budianu MA, Cotoi OS, Turdean SG, et al
    The importance of combined HPV and CINtec(R) PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
    Rom J Morphol Embryol. 2024;65:99-105.
    PubMed    
    Abstract available

  49. SNIADECKI M, Guani B, Jaworek P, Klasa-Mazurkiewicz D, et al
    Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A systematic review and a prototype of an adapted model of care.
    Crit Rev Oncol Hematol. 2024 Mar 23:104329.
    PubMed    
    Abstract available

  50. ZHANG Y, Hu Y, Zhao S, Xu S, et al
    Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on (18)F-FDG PET/CT.
    Abdom Radiol (NY). 2024 Mar 25. doi: 10.1007/s00261-024-04226.
    PubMed    
    Abstract available

  51. OOKO F
    Ensuring access to palliative care for cervical cancer patients.
    S Afr Med J. 2023;114:3-4.
    PubMed    


  52. GUAN P, Han X, Li D, Liao B, et al
    Effect of nurse-physician collaboration on the incidence of complications, negative emotions and quality of life in cervical cancer patients: a randomized controlled study.
    J Interprof Care. 2024 Mar 25:1-9. doi: 10.1080/13561820.2024.2327621.
    PubMed    
    Abstract available

  53. BELLOTTI JA, Gutierres IG, Furtado YL, Patury P, et al
    Surgical, oncologic, and obstetric outcomes of radical trachelectomy in early-stage cervical cancer: results from a retrospective cohort study at Brazil National Cancer Institute.
    Front Oncol. 2024;14:1267625.
    PubMed    
    Abstract available

  54. GHASEMI-GUJANI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Development of mobile application for cervical cancer screening in women: Protocol of a multi-phase study.
    J Educ Health Promot. 2024;13:5.
    PubMed    
    Abstract available

  55. CHAUHAN R, Goel A, Alankar B, Kaur H, et al
    Predictive modeling and web-based tool for cervical cancer risk assessment: A comparative study of machine learning models.
    MethodsX. 2024;12:102653.
    PubMed    
    Abstract available

  56. BURDIER FR, Waheed DE, Nedjai B, Steenbergen RDM, et al
    DNA methylation as a triage tool for cervical cancer screening - A meeting report.
    Prev Med Rep. 2024;41:102678.
    PubMed    
    Abstract available

  57. BALUWA PC, Moyo RC, Baluwa MA, Nyirenda L, et al
    Barriers Associated with Adherence to Cervical Cancer Screening Among Women Living with HIV in Nkhatabay District, Malawi: A Mixed-Methods Study.
    Int J Womens Health. 2024;16:491-507.
    PubMed    
    Abstract available

  58. ZRAIDI M, Ibriz M
    [The timeline of the screening and treatment strategy of intraepithelial neoplasia of the uterine cervix adopted in Morocco].
    Pan Afr Med J. 2024;47:13.
    PubMed    
    Abstract available

  59. AMORHA KC, Ozota GO, Ndunwere MO, Anyaji UL, et al
    Knowledge, attitudes, and practices of adolescent girls regarding cervical cancer: a cross-sectional study in Enugu State, Nigeria.
    Pan Afr Med J. 2024;47:17.
    PubMed    
    Abstract available

  60. ZHANG N, Guo MF
    Granulocyte-Macrophage Colony-Stimulating Factor in Combination With Chemoradiation for Recurrent or Metastatic Cervical Cancer.
    Cureus. 2024;16:e54573.
    PubMed    
    Abstract available

  61. FADL J, Aljuhani RA, Albog YH, Khraisat AF, et al
    Role of microRNA in Sex Steroid Hormones Signaling and Its Effect in Regulation of Endometrial, Ovarian, and Cervical Cancer: A Literature Review.
    Cureus. 2024;16:e54773.
    PubMed    
    Abstract available

  62. BABAYAN LM, Bouts C, Guntupalli S, Marjon NA, et al
    Exploring tisotumab vedotin in recurrent cervical cancer: A case series including an HPV-independent gastric type adenocarcinoma.
    Gynecol Oncol Rep. 2024;52:101356.
    PubMed    
    Abstract available

  63. PEREIRA IOA, Silva NNT, Lima AA, da Silva GN, et al
    Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
    Environ Mol Mutagen. 2024 Mar 24. doi: 10.1002/em.22591.
    PubMed    
    Abstract available

  64. LIU Y, Xin W, Wang P, Ji M, et al
    Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
    J Gynecol Oncol. 2024 Mar 11. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  65. CHO EH, Park MS, Woo HY, Park H, et al
    Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
    J Gynecol Oncol. 2024 Mar 15. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  66. GILYADOVA AV, Ishchenko AA, Samoilova SV, Shiryaev AA, et al
    Comparative study of treatment efficacy in severe intraepithelial squamous cell lesions and preinvasive cervical cancer by conization and chlorin e6-mediated fluorescence-assisted systemic photodynamic therapy.
    Photodiagnosis Photodyn Ther. 2024;46:104060.
    PubMed    
    Abstract available

  67. LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al
    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317.
    PubMed    
    Abstract available

  68. TEWARI KS, Monk BJ
    Immunotherapy plus chemoradiotherapy in cervical cancer management.
    Lancet. 2024 Mar 20:S0140-6736(24)00468-9. doi: 10.1016/S0140-6736(24)00468.
    PubMed    


  69. LE VN, Le VNB, Hoang XS, Le VD, et al
    Distribution of human papillomavirus among Vietnamese women with cervical cancer and unusual genetic variability of HPV16.
    Virology. 2024;594:110058.
    PubMed    
    Abstract available

  70. ALHERZ FA, Alamri AA, Aljbreen A, Alwallan N, et al
    Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia.
    J Infect Public Health. 2024;17:789-794.
    PubMed    
    Abstract available

  71. YUAN L, Jiang H, Jia Y, Liao Y, et al
    Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via Acetyl-CoA-Mediated Stemness.
    Adv Sci (Weinh). 2024 Mar 23:e2308422. doi: 10.1002/advs.202308422.
    PubMed    
    Abstract available

  72. KRISHNAMOORTHY S, Sabanayagam R, Periyasamy L, Muruganantham B, et al
    Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
    Med Oncol. 2024;41:89.
    PubMed    
    Abstract available

  73. ROMANO KD, Petroni G, Ward K, Zheng W, et al
    A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer.
    Brachytherapy. 2024 Mar 21:S1538-4721(24)00035.
    PubMed    
    Abstract available

  74. LALANDE E, Clarke H, Undurraga M, Nguyen VQH, et al
    Knowledge of cytology results affects the performance of colposcopy: a crossover study.
    BMC Womens Health. 2024;24:189.
    PubMed    
    Abstract available

  75. GOSECKA M, Gosecki M, Ziemczonek P, Urbaniak M, et al
    Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy.
    ACS Appl Mater Interfaces. 2024;16:14605-14625.
    PubMed    
    Abstract available

  76. GRACA J, Preti M, Pollano B, Vieira-Baptista P, et al
    Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
    J Low Genit Tract Dis. 2024;28:131-136.
    PubMed    
    Abstract available

  77. CLARKE MA, Wentzensen N, Perkins RB, Garcia F, et al
    Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
    J Low Genit Tract Dis. 2024;28:124-130.
    PubMed    
    Abstract available

  78. NAKAI H, Higashi T, Kakuwa T, Matsumura N, et al
    Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
    Int J Clin Oncol. 2024;29:363-371.
    PubMed    
    Abstract available

  79. WANG S, Ren W, Zhang B, Chen M, et al
    Knowledge, Attitude, and Uptake of Human Papillomavirus (HPV) Vaccination among Chinese Female Adults: A National Cross-sectional Web-Based Survey Based on a Large E-commerce Platform.
    Matern Child Health J. 2024;28:746-757.
    PubMed    
    Abstract available

  80. PARIKH S, Zhang Y, Sherwani Z, Kumar R, et al
    Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A systematic review.
    Brachytherapy. 2024;23:141-148.
    PubMed    
    Abstract available

  81. SOEGAARD-ANDERSEN E, Frandsen AP, Sandahl P
    Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study.
    J Low Genit Tract Dis. 2024;28:149-152.
    PubMed    
    Abstract available

  82. OWRANGI A, Medrano A, Gao Y, Kazemifar S, et al
    Definitive radiation for advanced cervix cancer is not associated with vaginal shortening-a prospective vaginal length and dose correlation.
    Brachytherapy. 2024;23:136-140.
    PubMed    
    Abstract available

  83. TAAVELA K, Eriksson T, Huhtala H, Bly A, et al
    The quality of life of frequently vs. infrequently screened HPV vaccinated women.
    Qual Life Res. 2024;33:941-949.
    PubMed    
    Abstract available

  84. HU B, Wang R, Wu D, Long R, et al
    A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers.
    Adv Sci (Weinh). 2024;11:e2302340.
    PubMed    
    Abstract available

  85. IKUSHIMA H, Ii N, Noda SE, Masui K, et al
    Patterns of care for brachytherapy in Japan.
    J Radiat Res. 2024;65:168-176.
    PubMed    
    Abstract available

  86. MANZAR GS, Alam MBE, Lynn EJ, Karpinets TV, et al
    Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.
    Brachytherapy. 2024;23:123-135.
    PubMed    
    Abstract available

  87. TAKATSU J, Murakami N, Muramoto Y, Karino T, et al
    Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
    Brachytherapy. 2024;23:115-122.
    PubMed    
    Abstract available

  88. DUTTA P, Pal D, Sultana F, Mandal RK, et al
    Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
    Reprod Sci. 2024;31:1122-1138.
    PubMed    
    Abstract available

  89. DEO BS, Sah AN, Shukla S, Pandey K, et al
    Cervical pre-cancer classification using entropic features and CNN: In vivo validation with a handheld fluorescence probe.
    J Biophotonics. 2024;17:e202300363.
    PubMed    
    Abstract available

  90. DOMBROWSKI C, Bourgain C, Ma Y, Meiwald A, et al
    An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing.
    Eur J Cancer Prev. 2024;33:262-270.
    PubMed    
    Abstract available

  91. ROURKE M, Fitzpatrick P, Popoola O, Boms R, et al
    The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland.
    Ir J Med Sci. 2024;193:665-668.
    PubMed    
    Abstract available

  92. GILMAN SD, Gravitt PE, Paz-Soldan VA
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: a case study from the Proyecto Precancer.
    Implement Sci Commun. 2024;5:35.
    PubMed    
    Abstract available

  93. TERGAS A, Byron S, Zhang G, Izatt T, et al
    YIA24-007: Genetic Ancestry and Genomic Alterations of Cervical Cancer in a Diverse Patient Population.
    J Natl Compr Canc Netw. 2024;22.
    PubMed    


  94. CHEN X, Duan H, Zhao H, He F, et al
    Perineural invasion in cervical cancer: A multicenter retrospective study.
    Eur J Surg Oncol. 2024;50:108313.
    PubMed    
    Abstract available

  95. WANG J, Guo H, Yang J, Mao J, et al
    Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
    Front Oncol. 2024;14:1374195.
    PubMed    
    Abstract available

  96. SONG X, Li X, Tan Z, Zhang L, et al
    Corrigendum: Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1395166.
    PubMed    
    Abstract available

  97. NAIK D, Kalle AM
    MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer.
    Noncoding RNA Res. 2024;9:732-743.
    PubMed    
    Abstract available

  98. CHEN D, Cai B, Zhu Y, Ma Y, et al
    Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Clin Epigenetics. 2024;16:51.
    PubMed    
    Abstract available

  99. ESPINOSA K
    ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
    Am Fam Physician. 2024;109:275-276.
    PubMed    


  100. ASWATHY R, Sumathi S
    The Evolving Landscape of Cervical Cancer: Breakthroughs in Screening and Therapy Through Integrating Biotechnology and Artificial Intelligence.
    Mol Biotechnol. 2024 Apr 4. doi: 10.1007/s12033-024-01124.
    PubMed    
    Abstract available

  101. OKYERE J, Ayebeng C, Dickson KS
    Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Cote d'Ivoire demographic and health survey.
    BMC Health Serv Res. 2024;24:423.
    PubMed    
    Abstract available

  102. KROG L, Lycke KD, Kahlert J, Randrup TH, et al
    Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
    Am J Obstet Gynecol. 2024;230:430.
    PubMed    
    Abstract available

  103. BAHADUR A, Mundhra R, Gill P, Singh A, et al
    Aggressive precursor B cell ALL of cervix with obstructive uropathy.
    BMJ Case Rep. 2024;17:e258313.
    PubMed    
    Abstract available

  104. ZHENG S, Zhang X, Greuter MJW, de Bock GH, et al
    Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    BMJ Open. 2024;14:e075604.
    PubMed    
    Abstract available

  105. VALLEJO-RUIZ V, Gutierrez-Xicotencatl L, Medina-Contreras O, Lizano M, et al
    Molecular aspects of cervical cancer: a pathogenesis update.
    Front Oncol. 2024;14:1356581.
    PubMed    
    Abstract available

  106. CORDOBA A, Gesta E, Escande A, Noeuveglise A, et al
    Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
    Front Oncol. 2024;14:1347727.
    PubMed    
    Abstract available

  107. ROCHA NSS, Clara BM, Luz LMM, do Rosario Oliveira Martins M, et al
    Knowledge, attitudes and practices of cervical cancer screening among female students enrolled in higher education institutions in Cabo Verde.
    Ecancermedicalscience. 2024;18:1689.
    PubMed    
    Abstract available

  108. HUSEINOVIC A, Xu M, Jaspers A, Bais B, et al
    miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
    J Med Virol. 2024;96:e29580.
    PubMed    
    Abstract available

  109. LIU P, Yang X, Zhao H, Liang L, et al
    High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
    Hum Vaccin Immunother. 2024;20:2337161.
    PubMed    
    Abstract available

  110. SEYFU DT, Abebe SN, Haile S, Ayana BA, et al
    Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
    BMC Womens Health. 2024;24:209.
    PubMed    
    Abstract available

  111. SIMUYEMBA MC, Chama-Chiliba CM, Chompolola A, Sinyangwe A, et al
    An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    BMC Infect Dis. 2024;24:369.
    PubMed    
    Abstract available

  112. SIDAWAY P
    Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2024 Apr 2. doi: 10.1038/s41571-024-00889.
    PubMed    


  113. YIN Q, Zhou Q, Hu J, Weng J, et al
    Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
    J Trace Elem Med Biol. 2024;84:127437.
    PubMed    
    Abstract available

  114. MA Y, Zhu W
    Development of gene panel for predicting recurrence in early-stage cervical cancer patients.
    Environ Toxicol. 2024 Apr 2. doi: 10.1002/tox.24270.
    PubMed    
    Abstract available

  115. ARVIZU-HERNANDEZ E, Hernandez-Guerrero CJ, Alvarez-Rios E, Gariglio P, et al
    Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
    J Med Virol. 2024;96:e29571.
    PubMed    
    Abstract available

  116. EFFAH K, Anthony R, Tekpor E, Amuah JE, et al
    HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Cancer Control. 2024;31:10732748241244678.
    PubMed    
    Abstract available

  117. LIANG KW, Chen LJ, Wang CH, Ma KS, et al
    Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.
    Front Immunol. 2024;15:1331994.
    PubMed    
    Abstract available

  118. ANYAKA CU, Alero BJ, Olukoya B, Envuladu EA, et al
    Parental Knowledge of HPV Infection, Cervical Cancer and the Acceptance of HPV Vaccination for their Children in Jos, Nigeria.
    J West Afr Coll Surg. 2024;14:146-153.
    PubMed    
    Abstract available

  119. GOSSE RA, Msengi EA, Chona EZ, Ambikile JS, et al
    Experiences of caring for women with cervical cancer: A qualitative study among male partners in Dar es Salaam, Tanzania.
    Health Expect. 2024;27:e14038.
    PubMed    
    Abstract available

  120. ZENG S, Yang P, Xiao S, Liu L, et al
    Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Sci Rep. 2024;14:7681.
    PubMed    
    Abstract available

  121. WANG Q, Wang B, Zhang W, Zhang T, et al
    APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
    Arch Biochem Biophys. 2024;755:109983.
    PubMed    
    Abstract available

  122. BATUR P
    For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0019.
    PubMed    
    Abstract available

  123. RODRIGUES IO, Duarte I, Costa CG, Pimentel AL, et al
    Knowledge about cervical cancer in young Portuguese women: a cross-sectional study.
    Front Public Health. 2024;12:1357606.
    PubMed    
    Abstract available

  124. GAZZETTA S, Valent F, Sala A, Driul L, et al
    Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy.
    Front Public Health. 2024;12:1336250.
    PubMed    
    Abstract available

  125. NAGAI H
    Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer.
    Cureus. 2024;16:e57144.
    PubMed    
    Abstract available

  126. DIVYA KT, Chidrawar VR, Bhupalam PK, Shiromwar S, et al
    Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh - India.
    J Educ Health Promot. 2024;13:73.
    PubMed    
    Abstract available

  127. YAMADA S, Fukugawa Y, Otsuka T, Saito T, et al
    Radiation-Induced Myonecrosis: A Case Report of a Cervical Cancer Patient With a History of Systemic Lupus Erythematosus.
    Cureus. 2024;16:e55134.
    PubMed    
    Abstract available

  128. LI N, Wang XL, Ge R, Wang Y, et al
    FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    J Cell Physiol. 2024 Apr 1. doi: 10.1002/jcp.31267.
    PubMed    
    Abstract available

  129. SAUVAGE LM, Bentahila R, Tran Y, Guenegou-Arnoux A, et al
    Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation: Analysis and Predictive Factors From a Retrospective Cohort.
    Am J Clin Oncol. 2024 Apr 1. doi: 10.1097/COC.0000000000001092.
    PubMed    
    Abstract available

  130. YOSHIMOTO M, Tokuda A, Eguchi A, Nozawa Y, et al
    Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
    Exp Cell Res. 2024;437:114018.
    PubMed    
    Abstract available

  131. KHAN NG, Adiga D, Rai PS, Kabekkodu SP, et al
    Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Toxicology. 2024;504:153791.
    PubMed    
    Abstract available

  132. NGABONZIZA E, Ghebre R, DeBoer RJ, Ntasumbumuyange D, et al
    Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
    BMC Womens Health. 2024;24:204.
    PubMed    
    Abstract available

  133. ZOU T, Gao Y, Qie M
    Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2.
    Arch Biochem Biophys. 2024 Mar 28:109980. doi: 10.1016/j.abb.2024.109980.
    PubMed    
    Abstract available

  134. DITTO A, Longo M, Chiarello G, Mariani L, et al
    Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
    Eur J Surg Oncol. 2024;50:108311.
    PubMed    
    Abstract available

  135. ANAND A, Raju K
    Significance of platelet parameters in invasive squamous cell carcinoma of uterine cervix.
    J Cancer Res Ther. 2024;20:139-143.
    PubMed    
    Abstract available

  136. LADBURY C, Eustace N, Kassardjian A, Amini A, et al
    Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
    Brachytherapy. 2024 Mar 28:S1538-4721(24)00010.
    PubMed    
    Abstract available

  137. GUO X, Zhao E, Guan Z, Li W, et al
    A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
    J Int Med Res. 2024;52:3000605241233966.
    PubMed    
    Abstract available

  138. SU D, Song X, Wu F, Fan S, et al
    Cervical clear cell carcinoma: Case report and literature review.
    Medicine (Baltimore). 2024;103:e37449.
    PubMed    
    Abstract available

  139. KONG Y, Liu S, Wang X, Qie R, et al
    Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37628.
    PubMed    
    Abstract available

  140. LI M, Zheng W
    Mature solid teratoma of the uterine cervix: A rare case report and review of the literature.
    Medicine (Baltimore). 2024;103:e37451.
    PubMed    
    Abstract available

  141. LI X, Zhang L, Huang X, Peng Q, et al
    High-throughput metabolomics identifies new biomarkers for cervical cancer.
    Discov Oncol. 2024;15:90.
    PubMed    
    Abstract available

  142. WANG S, Dang L, Liu S, Rezhake R, et al
    Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    JAMA Netw Open. 2024;7:e244090.
    PubMed    
    Abstract available

  143. XIAO H, Chen W, Lin M, Jiang S, et al
    Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
    Anal Methods. 2024;16:1862-1869.
    PubMed    
    Abstract available

  144. YANG L, Bu G, Zhao J, La X, et al
    Comparison of 3D and 2D laparoscopy: Initial experience of perioperative outcomes and clinical assessment.
    J Gynecol Obstet Hum Reprod. 2024;53:102754.
    PubMed    
    Abstract available

  145. TIAN X, Liu P, Kang S, Cui Z, et al
    Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Eur J Surg Oncol. 2024;50:107977.
    PubMed    
    Abstract available

  146. SAKURAI A, Yamanoi K, Yamaguchi K, Hamanishi J, et al
    Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
    J Obstet Gynaecol Res. 2024;50:758-763.
    PubMed    
    Abstract available

  147. PARTANEN VM, Dillner J, Trope A, Agustsson AI, et al
    Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
    Eur J Public Health. 2024;34:354-360.
    PubMed    
    Abstract available

  148. AKSOY C, Reimold P, Schumann A, Schneidewind L, et al
    Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students.
    Urol Int. 2024;108:153-158.
    PubMed    
    Abstract available

  149. NGO O, Chloupkova R, Cibula D, Slama J, et al
    Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
    Eur J Public Health. 2024;34:361-367.
    PubMed    
    Abstract available

  150. LI F, Chen A, Shan Y, Yao Y, et al
    Factors associated with human papillomavirus persistence after loop electrosurgical excision procedure in patients with cervical squamous intraepithelial lesion.
    J Obstet Gynaecol Res. 2024;50:639-646.
    PubMed    
    Abstract available

  151. ALQABBANI R, Chan J, Goldberg A
    Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
    Am J Clin Pathol. 2024;161:369-373.
    PubMed    
    Abstract available

  152. PARISI S, Sciacca M, Ferrantelli G, Chillari F, et al
    Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
    Jpn J Radiol. 2024;42:354-366.
    PubMed    
    Abstract available

  153. YAHIA A, Cole E, Rayford A, Fava J, et al
    A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university.
    J Am Coll Health. 2024;72:500-508.
    PubMed    
    Abstract available

  154. ROSENBLUM HG, Gargano JW, Cleveland AA, Dahl RM, et al
    U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0462.
    PubMed    
    Abstract available

  155. ZHAO X, Fan X, Lin X, Guo B, et al
    Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
    Medicine (Baltimore). 2024;103:e37717.
    PubMed    
    Abstract available

  156. LI C, Li J, Lu Y, Hou J, et al
    Observations of the effectiveness, dosage, and prognosis of intensity-modulated radiation therapy under ultrasonic guidance for cervical cancer patients.
    Technol Health Care. 2024 Feb 29. doi: 10.3233/THC-231977.
    PubMed    
    Abstract available

  157. COCHRANE AC, Bullington BW, Prokopowicz C, Rahangdale L, et al
    Comparing Cervical Cancer Screening Strategies in an Incarcerated Population.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0513.
    PubMed    
    Abstract available

  158. BUENO-URQUIZA LJ, Godinez-Rubi M, Villegas-Pineda JC, Vega-Magana AN, et al
    Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker.
    Cells. 2024;13:560.
    PubMed    
    Abstract available

  159. FANG C, Zhou Y, Feng Y, He L, et al
    QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
    J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  160. LIZANO M, Carrillo-Garcia A, De La Cruz-Hernandez E, Castro-Munoz LJ, et al
    Promising predictive molecular biomarkers for cervical cancer (Review).
    Int J Mol Med. 2024;53:50.
    PubMed    
    Abstract available

  161. BARQUET-MUNOZ SA, Arteaga-Gomez C, Diaz-Lopez E, Rodriguez-Trejo A, et al
    Current status and challenges in timely detection of cervical cancer in Mexico: expert consensus.
    Front Oncol. 2024;14:1383105.
    PubMed    
    Abstract available

  162. FINCH LA, Levy MS, Thiele A, Jeudin P, et al
    Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.
    Front Oncol. 2024;14:1359160.
    PubMed    
    Abstract available

  163. GUTIERREZ SALMEAN G, Delgadillo Gonzalez M, Rueda Escalona AA, Leyva Islas JA, et al
    Effects of prebiotics, probiotics, and synbiotics on the prevention and treatment of cervical cancer: Mexican consensus and recommendations.
    Front Oncol. 2024;14:1383258.
    PubMed    
    Abstract available

  164. SAHA I, Halder J, Rajwar TK, Mahanty R, et al
    Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.
    AAPS PharmSciTech. 2024;25:85.
    PubMed    
    Abstract available

  165. KIM H, Yoo SK, Kim JS, Kim YT, et al
    Clinical feasibility of deep learning-based synthetic CT images from T2-weighted MR images for cervical cancer patients compared to MRCAT.
    Sci Rep. 2024;14:8504.
    PubMed    
    Abstract available

  166. ZHANG Y, Li L, Han Q, Wen L, et al
    The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    J Obstet Gynaecol. 2024;44:2333784.
    PubMed    
    Abstract available

  167. JIBAT N, Ali R, Adissu W, Buruh G, et al
    Less known but greatly feared: Cervical cancer in Ethiopia community awareness.
    Heliyon. 2024;10:e28328.
    PubMed    
    Abstract available

  168. CHEN J, Zhang R, Xu W, Bai L, et al
    Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:e55930.
    PubMed    
    Abstract available

  169. KHOSHNAZAR MS, Tarrahi MJ, Shahnazi H
    Impact of virtual education based on health belief model on cervical cancer screening behavior in middle-aged women: A quasi-experimental study.
    Cancer Rep (Hoboken). 2024;7:e2058.
    PubMed    
    Abstract available

  170. YIN J, Zhang S, Li Z, Li Y, et al
    Impact of high-performance HPV testing to improve cervical cancer screening in China: A prospective population-based multicenter cohort study.
    Clin Microbiol Infect. 2024 Apr 8:S1198-743X(24)00166.
    PubMed    
    Abstract available

  171. SONKER P, Tamang R, Mehata AK, Nidhar M, et al
    PTSA-induced synthesis, in silico and nano study of novel ethylquinolin-thiazolo-triazole in cervical cancer.
    Future Med Chem. 2024 Apr 10. doi: 10.4155/fmc-2023-0344.
    PubMed    
    Abstract available

  172. NAAMALA A, Eriksson LE, Orem J, Nalwadda GK, et al
    Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional study.
    Glob Health Action. 2024;17:2325728.
    PubMed    
    Abstract available

  173. WANG D, Zou F, Li Y, Hu J, et al
    Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.
    Mol Ther Oncol. 2024;32:200759.
    PubMed    
    Abstract available

  174. JIANG R, Li X, Cao S, Wu Y, et al
    Nodal staging score for adequacy of nodal staging in cervical cancer.
    Heliyon. 2024;10:e26116.
    PubMed    
    Abstract available

  175. NUZHATH FJ, Patil NJ, Sheela SR, Manjunath GN, et al
    A Randomized Controlled Trial on Pranayama and Yoga Nidra for Anxiety and Depression in Patients With Cervical Cancer Undergoing Standard of Care.
    Cureus. 2024;16:e55871.
    PubMed    
    Abstract available

  176. LIN G, Ma C, Wu C, Si Y, et al
    [Application of microchannel technique in minimally invasive resection of cervical intraspinal tumors].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2024;56:318-321.
    PubMed    
    Abstract available

  177. LI W, Ma L, Li F, Li K, et al
    Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
    Radiat Oncol. 2024;19:46.
    PubMed    
    Abstract available

  178. LIN G, Hsieh CY, Lai YC, Wang CC, et al
    Hyperpolarized [1-(13)C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer.
    Eur Radiol Exp. 2024;8:46.
    PubMed    
    Abstract available

  179. ADAMS RA, Botha MH
    Cervical cancer prevention in Southern Africa: a review of national cervical cancer screening guidelines in the Southern African Development Community.
    J Cancer Policy. 2024 Apr 7:100477. doi: 10.1016/j.jcpo.2024.100477.
    PubMed    
    Abstract available

  180. LI J
    Relationships among health-related social media use, knowledge, worry, and cervical cancer screening: A cross-sectional study of US females.
    Patient Educ Couns. 2024;124:108283.
    PubMed    
    Abstract available


  181. Retraction: "Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway".
    J Cell Physiol. 2024 Apr 9. doi: 10.1002/jcp.31239.
    PubMed    
    Abstract available

  182. SSEDYABANE F, Ngonzi J, Tusubira D, Nambi Najjuma J, et al
    Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
    Gynecol Oncol Rep. 2024;53:101388.
    PubMed    
    Abstract available

  183. YAO X, Li Q, Chen Y, Du Z, et al
    Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Front Public Health. 2024;12:1332696.
    PubMed    
    Abstract available

  184. MAITRA S, Mukerjee N, Alharbi HM, Ghosh A, et al
    Targeted therapies for HPV-associated cervical cancer: Harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer.
    J Med Virol. 2024;96:e29596.
    PubMed    
    Abstract available

  185. UEDA Y
    Epidemiology of cervical cancer and HPV infection in Asia and Oceania.
    J Obstet Gynaecol Res. 2024 Apr 8. doi: 10.1111/jog.15943.
    PubMed    
    Abstract available

  186. CHOI SY, Kim S, Jeon JY, Kim MG, et al
    Metabolomic Profiles in Patients with Cervical Cancer Undergoing Cisplatin and Radiation Therapy.
    Biomol Ther (Seoul). 2024 Apr 9. doi: 10.4062/biomolther.2023.
    PubMed    
    Abstract available

  187. MUNGO C, Ellis GK, Rop M, Zou Y, et al
    Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
    medRxiv [Preprint]. 2024 Mar 6:2024.03.05.24303779.
    PubMed    
    Abstract available

  188. LI Y, Man X, Zhang Q, Wang X, et al
    Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner.
    Open Life Sci. 2024;19:20220819.
    PubMed    
    Abstract available

  189. JAMADAGNI S, Ponni Tr A, P R
    Dosimetric comparison of intra-cavitary brachytherapy technique with free-hand (intra-cavitary + interstitial) technique in cervical cancer.
    J Contemp Brachytherapy. 2024;16:28-34.
    PubMed    
    Abstract available

  190. SONG C, Chen L
    Circ_0051428 targeting miR-885-3p/MMP2 axis enhances the malignancy of cervical cancer.
    Open Med (Wars). 2024;19:20230858.
    PubMed    
    Abstract available

  191. WANG SF, Du CY, Li M, Wen B, et al
    Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
    Technol Cancer Res Treat. 2024;23:15330338241242637.
    PubMed    
    Abstract available

  192. WU Z, Liu M, Pang Y, Deng L, et al
    A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc Therapy.
    Technol Cancer Res Treat. 2024;23:15330338241242654.
    PubMed    
    Abstract available

  193. BAI Y, Miao Y, Wang J, Gan J, et al
    Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer.
    Biochem Genet. 2024 Apr 8. doi: 10.1007/s10528-024-10782.
    PubMed    
    Abstract available

  194. GOPALANI SV, Sawaya GF, Rositch AF, Dasari S, et al
    The Impact of Adjusting for Hysterectomy Prevalence on Cervical Cancer Incidence Rates and Trends Among Women Aged 30 Years and Older - United States, 2001-2019.
    Am J Epidemiol. 2024 Apr 6:kwae041. doi: 10.1093.
    PubMed    
    Abstract available

  195. LIU Z, Yang Z, Ablise M
    Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.
    Bioorg Chem. 2024;147:107310.
    PubMed    
    Abstract available

  196. LIU B, Gao H, Zhou F, Zhao W, et al
    Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Clin Radiol. 2024 Mar 15:S0009-9260(24)00128-4. doi: 10.1016/j.crad.2024.
    PubMed    
    Abstract available

  197. EL-NASHAR HAS, Al-Azzawi MA, Al-Kazzaz HH, Alghanimi YK, et al
    HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
    J Pharm Biomed Anal. 2024;244:116121.
    PubMed    
    Abstract available

  198. WELSH A, Matshitse R, Khan SF, Nyokong T, et al
    Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment.
    J Inorg Biochem. 2024;256:112545.
    PubMed    
    Abstract available

  199. LI X, Ou C, He A
    Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
    Medicine (Baltimore). 2024;103:e37680.
    PubMed    
    Abstract available

  200. XU M, Wang Y
    Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.
    BMC Womens Health. 2024;24:220.
    PubMed    
    Abstract available

  201. ABATE A, Munshea A, Nibret E, Alemayehu DH, et al
    Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
    Sci Rep. 2024;14:7976.
    PubMed    
    Abstract available

  202. ZHAO C, Zhao Y, Li J, Li M, et al
    Opportunities and challenges for human papillomavirus vaccination in China.
    Hum Vaccin Immunother. 2024;20:2329450.
    PubMed    
    Abstract available

  203. MALDONADO I, Rodriguez Nino N, Valencia CF, Ortiz D, et al
    Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
    Vaccine. 2024 Mar 7:S0264-410X(24)00263-9. doi: 10.1016/j.vaccine.2024.
    PubMed    
    Abstract available

  204. TOTZKAY D
    The potential influence of patient-centered communication, online provider communication, and social determinants of health on cancer screening.
    Patient Educ Couns. 2024;123:108238.
    PubMed    
    Abstract available

  205. LIU Y, Yan Q, Zeng Z, Fan C, et al
    Advances and prospects of mRNA vaccines in cancer immunotherapy.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189068.
    PubMed    
    Abstract available

  206. LOHR AM, Capetillo GP, Molina L, Goodson M, et al
    Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation.
    J Cancer Educ. 2024;39:160-167.
    PubMed    
    Abstract available

  207. ZHANG Y, Lei Y, Ou Q, Chen M, et al
    Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
    BMC Biol. 2024;22:88.
    PubMed    
    Abstract available

  208. SHEN J, Sun H, Chu J, Gong X, et al
    Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.
    Infect Agent Cancer. 2024;19:13.
    PubMed    
    Abstract available

  209. OKYERE J, Ayebeng C, Dosoo AK, Dickson KS, et al
    Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    BMC Public Health. 2024;24:1093.
    PubMed    
    Abstract available

  210. KASHID SR, Gurram L, Pullan S, Chopra S, et al
    Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
    Brachytherapy. 2024 Apr 18:S1538-4721(24)00047.
    PubMed    
    Abstract available

  211. XIAO Y, Yu R, Gu J
    Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the National Remote Emergency System: A case report.
    Medicine (Baltimore). 2024;103:e37699.
    PubMed    
    Abstract available

  212. CHEN XX, Nie C, Rao DF, Chen XX, et al
    The effect of refined psychological pain nursing combined with IMB nursing on the pain, sleep and quality of life of patients after cervical cancer surgery.
    Medicine (Baltimore). 2024;103:e37816.
    PubMed    
    Abstract available

  213. ZHOU L, Bi Y, Wu X, He H, et al
    High keratin 15 expression reflects favorable prognosis in early cervical cancer patients.
    Ir J Med Sci. 2024 Apr 19. doi: 10.1007/s11845-024-03686.
    PubMed    
    Abstract available

  214. HU J, Wang S, Li X
    A comprehensive review of m(6)A research in cervical cancer.
    Epigenomics. 2024 Apr 19. doi: 10.2217/epi-2024-0002.
    PubMed    
    Abstract available

  215. ZHANG G, Su G
    Efficacy and Safety of Recombinant Human p53 Adenovirus Injection Combined with Radiotherapy or Concurrent Chemoradiotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-analysis.
    Altern Ther Health Med. 2024 Apr 18:AT10189.
    PubMed    
    Abstract available

  216. LI E, Ni H
    Prognostic nomogram for early-stage cervical cancer in the elderly: A SEER database analysis.
    Prev Med Rep. 2024;41:102700.
    PubMed    
    Abstract available

  217. TAKAGAWA Y, Izumi S, Takahashi E, Kita M, et al
    Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
    BMC Womens Health. 2024;24:249.
    PubMed    
    Abstract available

  218. LIU K, Yang W, Tian H, Li Y, et al
    Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient s immunotherapy selection.
    Eur Radiol. 2024 Apr 18. doi: 10.1007/s00330-024-10759.
    PubMed    
    Abstract available

  219. DEO BS, Nayak S, Pal M, Panigrahi PK, et al
    Wavelet scattering transform and entropy features in fluorescence spectral signal analysis for cervical cancer diagnosis.
    Biomed Phys Eng Express. 2024 Apr 18. doi: 10.1088/2057-1976.
    PubMed    
    Abstract available

  220. BUCHALET C, Loap P, Losa S, Laas E, et al
    Long-term clinical outcomes of preoperative brachytherapy in early-stage cervical cancer.
    Eur J Surg Oncol. 2024;50:108342.
    PubMed    
    Abstract available

  221. LI SS, Chen JJ, Zhang MM, Wang WX, et al
    Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
    Eur J Med Chem. 2024;271:116425.
    PubMed    
    Abstract available

  222. CHEN YC, Chen YY, Su SY, Jhuang JR, et al
    Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study.
    JMIR Public Health Surveill. 2024;10:e46360.
    PubMed    
    Abstract available

  223. LIU XQ, Wang L, Gu X, Shan X, et al
    The Experience of Cervical Cancer Patients Undergoing Hysterectomy: A Qualitative Study.
    J Transcult Nurs. 2024 Apr 18:10436596241246976. doi: 10.1177/10436596241246976.
    PubMed    
    Abstract available

  224. MA Y, Zhao X, Chen X
    Contrast-enhanced ultrasound combined with elastic imaging for predicting the efficacy of concurrent chemoradiotherapy in cervical cancer: a feasibility study.
    Front Oncol. 2024;14:1301900.
    PubMed    
    Abstract available

  225. LIU C, Yuan Z, Liu Q, Song K, et al
    Siamese deep learning video flow cytometry for automatic and label-free clinical cervical cancer cell analysis.
    Biomed Opt Express. 2024;15:2063-2077.
    PubMed    
    Abstract available

  226. WU Z, Jia X, Lu L, Xu C, et al
    Multi-center Dose Prediction Using Attention-aware Deep learning Algorithm Based on Transformers for Cervical Cancer Radiotherapy.
    Clin Oncol (R Coll Radiol). 2024 Mar 26:S0936-6555(24)00119.
    PubMed    
    Abstract available

  227. HERNANDEZ-PADILLA L, Duran-Maldonado MX, Martinez-Alcantar L, Rodriguez-Zavala JS, et al
    The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
    Curr Cancer Drug Targets. 2024 Apr 15. doi: 10.2174/0115680096285034240323035013
    PubMed    
    Abstract available

  228. YIFAN M, Rui X, Yuan L, Feiyun J, et al
    Allicin inhibits the biological activities of cervical cancer cells by suppressing circEIF4G2.
    Food Sci Nutr. 2024;12:2523-2536.
    PubMed    
    Abstract available

  229. WANG Y, Lv B, Wang H, Ren T, et al
    Ultrasound-Triggered Azo Free Radicals for Cervical Cancer Immunotherapy.
    ACS Nano. 2024 Apr 16. doi: 10.1021/acsnano.3c10625.
    PubMed    
    Abstract available

  230. GRINCEVICIENE S, Vaitkiene D, Kanopiene D, Vanseviciute Petkeviciene R, et al
    Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:8789.
    PubMed    
    Abstract available

  231. SPENCER JC, Charlton BM, Pretsch PK, Schnarrs PW, et al
    Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina.
    Arch Sex Behav. 2024 Apr 16. doi: 10.1007/s10508-024-02844.
    PubMed    
    Abstract available

  232. MAPAONA R, Williams V, Musarapasi N, Kibwana S, et al
    Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.
    PLOS Glob Public Health. 2024;4:e0002760.
    PubMed    
    Abstract available

  233. WANG N, Xu J, Wang Y, Zhang X, et al
    USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
    J Cancer Res Clin Oncol. 2024;150:196.
    PubMed    
    Abstract available

  234. WANG Z, Cho H, Choyke P, Levy D, et al
    A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer.
    Bull Math Biol. 2024;86:57.
    PubMed    
    Abstract available

  235. ITO K, Nakajima Y, Ogawa H, Furusawa A, et al
    Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.
    Jpn J Radiol. 2024 Apr 16. doi: 10.1007/s11604-024-01566.
    PubMed    
    Abstract available

  236. YU L, Majerciak V, Lobanov A, Mirza S, et al
    HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
    mBio. 2024 Apr 16:e0072924. doi: 10.1128/mbio.00729.
    PubMed    
    Abstract available

  237. SHARIATI SARCHESHME M, Mahdizadeh M, Tehrani H, Vahedian-Shahroodi M, et al
    Exploring the barriers to Pap smear test compliance: A qualitative study for improving cervical cancer screening in the primary health care.
    Health Promot Perspect. 2024;14:80-88.
    PubMed    
    Abstract available

  238. SHA S, R J Goyette E, West LA, Bentz JL, et al
    Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer.
    Gynecol Oncol Rep. 2024;53:101382.
    PubMed    
    Abstract available

  239. ZENG Z, Zhu J, Wang Z, Wang G, et al
    Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
    Radiat Oncol. 2024;19:48.
    PubMed    
    Abstract available

  240. XU M, Lin MC, Li ZH
    Interferon-gamma-induced GBP1 is an inhibitor of human papillomavirus 18.
    BMC Womens Health. 2024;24:240.
    PubMed    
    Abstract available

  241. CHO O, Chun M, Chang SJ
    Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.
    Sci Rep. 2024;14:8710.
    PubMed    
    Abstract available

  242. SONG L, Gao Y, Wang Z, Shi Y, et al
    Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2024;84:370-377.
    PubMed    
    Abstract available

  243. LIU P, Xie L, Wu Q, Huang L, et al
    TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.
    Int J Biol Sci. 2024;20:2297-2309.
    PubMed    
    Abstract available

  244. JIN L, Cao F, Zhang Y, Dang Y, et al
    Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Transl Cancer Res. 2024;13:1323-1335.
    PubMed    
    Abstract available

  245. ZHANG R, Xu W, Yang S, Hu D, et al
    Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:e58081.
    PubMed    
    Abstract available

  246. TIAN W, Tan S, Wang J, Shen P, et al
    Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
    Discov Oncol. 2024;15:119.
    PubMed    
    Abstract available

  247. MARIN-AQUINO LA, Mora-Garcia ML, Moreno-Lafont MC, Garcia-Rocha R, et al
    Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A(2A)R/A(2B)R and the production of TGF-beta1.
    Cell Biochem Funct. 2024;42:e4010.
    PubMed    
    Abstract available

  248. AGUILAR-MARTINEZ SY, Campos-Viguri GE, Medina-Garcia SE, Garcia-Flores RJ, et al
    MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.
    Int J Mol Sci. 2024;25:4086.
    PubMed    
    Abstract available

  249. PANTE GC, Castro JC, Lini RS, Romoli JCZ, et al
    Inclusion Complexes of Litsea cubeba (Lour.) Pers Essential Oil into beta-Cyclodextrin: Preparation, Physicochemical Characterization, Cytotoxicity and Antifungal Activity.
    Molecules. 2024;29:1626.
    PubMed    
    Abstract available

  250. BEBIA V, Diaz-Feijoo B, Tejerizo A, Torne A, et al
    Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
    Cancers (Basel). 2024;16:1423.
    PubMed    
    Abstract available

  251. JACQUES C, Marchand F, Chatelais M, Albinet V, et al
    The Micro-Immunotherapy Medicine 2LPAPI((R)) Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer C
    Cancers (Basel). 2024;16:1421.
    PubMed    
    Abstract available

  252. LE GUEVELOU J, Selleret L, Laas E, Lecuru F, et al
    Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies.
    Cancers (Basel). 2024;16:1341.
    PubMed    
    Abstract available

  253. BELLOSILLO B, Ibanez R, Roura E, Monfil L, et al
    Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
    Cancers (Basel). 2024;16:1322.
    PubMed    
    Abstract available

  254. BALCIUNIENE E, Inciura A, Juozaityte E, Ugenskiene R, et al
    Impact of RRP1B Variants on the Phenotype, Progression, and Metastasis of Cervical Cancer.
    Cancers (Basel). 2024;16:1250.
    PubMed    
    Abstract available

  255. OZTURK NY, Hossain SZ, Mackey M, Adam S, et al
    HPV and Cervical Cancer Awareness and Screening Practices among Migrant Women: A Narrative Review.
    Healthcare (Basel). 2024;12:709.
    PubMed    
    Abstract available

  256. DOUGLAS R, Olanrewaju A, Mumme R, Zhang L, et al
    Evaluating automatically generated normal tissue contours for safe use in head and neck and cervical cancer treatment planning.
    J Appl Clin Med Phys. 2024 Apr 12:e14338. doi: 10.1002/acm2.14338.
    PubMed    
    Abstract available

  257. LIN W, Yao B, He J, Lin S, et al
    The effect of physical therapy and mechanical stimulation on dysfunction of lower extremities after total pelvic exenteration in cervical carcinoma patient with rectovesicovaginal fistula induced by radiotherapy: a case report.
    J Med Case Rep. 2024;18:207.
    PubMed    
    Abstract available

  258. HUANG Y, Pan C, Wu S, Ye F, et al
    A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer.
    Discov Oncol. 2024;15:116.
    PubMed    
    Abstract available

  259. VOVK V, Duda I, Vovk A
    THE EFFECT OF A MULTIMODAL APPROACH ON THE RESULTS OF TREATMENT IN SURGERY: INTEGRATION OF CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY.
    Georgian Med News. 2024;:41-46.
    PubMed    
    Abstract available

  260. YAN Z, Chang C, Kang Z, Chen C, et al
    Application of one-dimensional hierarchical network assisted screening for cervical cancer based on Raman spectroscopy combined with attention mechanism.
    Photodiagnosis Photodyn Ther. 2024 Apr 10:104086.
    PubMed    
    Abstract available

  261. OAKNIN A, Moore K, Meyer T, Lopez-Picazo Gonzalez J, et al
    Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
    Lancet Oncol. 2024 Apr 9:S1470-2045(24)00088.
    PubMed    
    Abstract available

  262. LAURIE C, El-Zein M, Tota JE, Tellier PP, et al
    Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
    J Med Virol. 2024;96:e29604.
    PubMed    
    Abstract available

  263. CHOI CH, Lee JW, Bae DS, Kang ES, et al
    Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
    Front Immunol. 2024;15:1371353.
    PubMed    
    Abstract available

  264. WAMUTI B, Jamil MS, Siegfried N, Ford N, et al
    Understanding effective post-test linkage strategies for HIV prevention and care: a scoping review.
    J Int AIDS Soc. 2024;27:e26229.
    PubMed    
    Abstract available

  265. LUO Y, Liu T, Yang X, Lu M, et al
    Human papillomavirus vaccination and contributing factors of vaccination intention among adolescents and young adults in China from a socio-ecological perspective: A cross-sectional study.
    Public Health Nurs. 2024;41:602-616.
    PubMed    
    Abstract available

  266. KNISELY A, Hinchcliff E, Fellman B, Mosley A, et al
    Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
    Med. 2024;5:311-320.
    PubMed    
    Abstract available

  267. PERGIALIOTIS V, Papageorgiou D, Douligeris A, Mortaki A, et al
    Awareness, knowledge and attitudes of human papillomavirus infection, screening and vaccination: a survey study in Greece.
    Arch Gynecol Obstet. 2024;309:2031-2040.
    PubMed    
    Abstract available

  268. GARDELLA B, Dominoni M, Pasquali MF, Gotti M, et al
    Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation.
    Gynecol Obstet Invest. 2024;89:95-102.
    PubMed    
    Abstract available

  269. HAWKINS KE, Gourlay K, Cuschieri K
    Challenges for cervical screening in people experiencing homelessness.
    BMJ Sex Reprod Health. 2024;50:150-151.
    PubMed    


  270. SZALAI L, Vereczkey I, Szemes M, Rokusz A, et al
    NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
    Virchows Arch. 2024;484:527-531.
    PubMed    
    Abstract available

  271. TRAN TXM, Kim S, Cha C, Park B, et al
    Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Cancer Res Treat. 2024;56:522-530.
    PubMed    
    Abstract available

  272. BRITO MJ, Sequeira P, Quintas A, Silva I, et al
    Programmed death-ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and cervical squamous cell carcinoma of HIV-infected and non-infected patients.
    Virchows Arch. 2024;484:507-516.
    PubMed    
    Abstract available

  273. TEMMINGHOFF L, Russell C, Andersson T, Broun K, et al
    Barriers and enablers to participation in the National Cervical Screening Program experienced by young women and people with a cervix aged between 25 and 35.
    Health Promot J Austr. 2024;35:376-384.
    PubMed    
    Abstract available

  274. FLORENCE AM, Fogel J, Mozey M, Dave S, et al
    Therapeutic human papilloma virus vaccination in patients at risk for cervical dysplasia.
    Minerva Obstet Gynecol. 2024;76:127-134.
    PubMed    
    Abstract available

  275. UCAK R, Dilbaz OF, Polat N
    Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
    Acta Cytol. 2024;68:54-59.
    PubMed    
    Abstract available

  276. BOHLIN KS, Brannstrom M, Dahm-Kahler P
    Gynecological cancer during pregnancy-From a gyne-oncological perspective.
    Acta Obstet Gynecol Scand. 2024 Jan 6. doi: 10.1111/aogs.14763.
    PubMed    
    Abstract available

  277. HARRIS CA, Mandelbaum RS, Rau AR, Song BB, et al
    Contraception and sterilization selection at delivery among pregnant patients with malignancy.
    Acta Obstet Gynecol Scand. 2023 Aug 14. doi: 10.1111/aogs.14654.
    PubMed    
    Abstract available

  278. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
    Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
    PubMed    
    Abstract available

  279. RUIZ F, Tjendra Y, Millan N, Gomez-Fernandez C, et al
    Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Am J Surg Pathol. 2024 Feb 15. doi: 10.1097/PAS.0000000000002193.
    PubMed    
    Abstract available

  280. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
    Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
    PubMed    
    Abstract available

  281. LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
    Factors contributing to differences in cervical cancer screening in rural and urban community health centers.
    Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
    PubMed    
    Abstract available

  282. TUNINETTI V, Virano E, Salutari V, Ricotti A, et al
    Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
    Eur J Cancer. 2024;203:114039.
    PubMed    
    Abstract available

  283. CEA GARCIA J, Rodriguez Jimenez I, Marquez Maraver F, Rios-Pena L, et al
    Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:78-85.
    PubMed    
    Abstract available

  284. LUO Y, Ma X
    Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:72-77.
    PubMed    
    Abstract available

  285. LIU S, Zhang W, Wang W, Zheng J, et al
    Topical delivery of drugs in the treatment of high-grade cervical squamous intraepithelial lesions: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:131-139.
    PubMed    
    Abstract available

  286. CHOI KH, Lee HC, Kim YS, Park W, et al
    Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study.
    Gynecol Oncol. 2024;182:45-50.
    PubMed    
    Abstract available

  287. VESZTERGOM D, Teglas G, Bahrehmand K, Torok A, et al
    Reducing radicality in fertility-sparing surgery is associated with improved in vitro fertilization outcome in early-stage cervical cancer: A national retrospective study.
    Gynecol Oncol. 2024;186:35-41.
    PubMed    
    Abstract available

  288. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    PubMed    
    Abstract available

  289. WEN TM, Xu XQ, Zhao XL, Pan CH, et al
    Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide.
    Int J Cancer. 2024 Feb 17. doi: 10.1002/ijc.34882.
    PubMed    
    Abstract available

  290. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    PubMed    
    Abstract available

  291. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    PubMed    
    Abstract available

  292. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.
    PubMed    


  293. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    PubMed    
    Abstract available

  294. KOHLER C, Plaikner A, Siegler K, Hertel H, et al
    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274.
    PubMed    
    Abstract available

  295. COLSON-FEARON D, Han K, Roumeliotis MB, Viswanathan AN, et al
    Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Int J Radiat Oncol Biol Phys. 2024;119:154-162.
    PubMed    
    Abstract available

  296. TROISI R, Bertrand K, Hatch EE, Strohsnitter WC, et al
    An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract.
    Obstet Gynecol. 2024;143:603-606.
    PubMed    
    Abstract available

  297. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    PubMed    
    Abstract available

  298. LI X, Zhao Y, Xiang F, Zhang X, et al
    Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
    BMC Cancer. 2024;24:381.
    PubMed    
    Abstract available

  299. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
    Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
    BMC Cancer. 2024;24:375.
    PubMed    
    Abstract available

  300. LI Z, Zhou G, Jiang L, Wang M, et al
    Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
    BMC Cancer. 2024;24:401.
    PubMed    
    Abstract available

  301. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
    Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    BMC Cancer. 2024;24:450.
    PubMed    
    Abstract available

  302. GU Z, Yang C, Zhang K, Wu H, et al
    Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
    BMC Cancer. 2024;24:492.
    PubMed    
    Abstract available

  303. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    PubMed    
    Abstract available

  304. LEMLEM SB, Gary RA, Yeager KA, Sisay MM, et al
    Psychometric properties of a modified health belief model for cervical cancer and visual inspection with acetic acid among healthcare professionals in Ethiopia.
    PLoS One. 2024;19:e0295905.
    PubMed    
    Abstract available

  305. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
    PLoS One. 2024;19:e0300763.
    PubMed    
    Abstract available

  306. DUA R, Bhardwaj T, Ahmad I, Somvanshi P, et al
    Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    PLoS One. 2024;19:e0287864.
    PubMed    
    Abstract available

  307. BELLONE S, Jeong K, Halle MK, Krakstad C, et al
    Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Proc Natl Acad Sci U S A. 2024;121:e2321898121.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;